Uncommon/rare oncogenic drivers in non‐small cell lung cancer: Consensus and contention

Autor: Yi‐Long Wu, Shun Lu, Ying Cheng, Qing Zhou, Hai‐Yan Tu, Qing‐Hua Zhou, Lv‐Hua Wang, Li Zhang, Jian‐Ying Zhou, Cheng Huang, Ming Chen, Cheng‐Ping Hu, Shao‐Kun Chuai, Xiao‐Nan Wang, Xiao‐Qing Liu, Ji‐Wei Liu, Peng‐Hui Zhou, Wei‐Zhi Chen, Ling‐Hua Yan, Yun‐Peng Liu, An‐Wen Liu, Xu‐Chao Zhang, Hui Li, Rong‐Rong Chen, Dong‐Mei Lin, Cong‐Ying Xie, Zheng‐Fei Zhu, Hui‐Ying Liang, Yong Song, Xiao‐Rong Dong, Ming‐Fang Zhao, Gui‐Bin Qiao, Jiu‐Wei Cui, Zi‐Ming Li, Zhi‐Jie Wang, Xiao‐Yuan Chen, Nong Yang, Gen Lin, Pan‐Wen Tian, Yun Fan, Qi‐Bin Song, Yuan Chen, Jian‐Chun Duan, Jia‐Lei Wang, Bo Zhu, Bu‐Hai Wang, Jun Zhao, Qi‐Tao Yu, Li‐Feng Wang, Hai‐Bo Zhang, Jie Hu, Rui Ma, Tong‐Mei Zhang, Jie Lin, Qian Chu, Sheng‐Xiang Ren, Yu Yao, Lin Wu, Hui‐Juan Wang, Fang Wu, Wen‐Zhao Zhong, Yi Hu, Ke‐Neng Chen, Jian Zhao, Fan Yang, Qun Wang, Dong‐Sheng Yue, Jian‐Ya Zhou, Peng Shen, Jia‐Tao Zhang, Xiao‐Long Yan, Mei‐Juan Huang, Wei‐Neng Feng, Li Li, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG)

Publikováno v: Medicine Advances, Vol 1, Iss 4, Pp 293-305 (2023)

Abstract The importance of uncommon/rare oncogenic drivers in non‐small cell lung cancer (NSCLC) was underscored during the 20th China Lung Cancer Summit. These drivers, while present in a significant proportion of NSCLC patients, remain a challeng

Externí odkaz: https://doaj.org/article/6cf86ef452334af4a74e37fd66750545

Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.

Autor: Jing-lei Qu, Xiu-juan Qu, Zhi Li, Jing-dong Zhang, Jing Liu, Yue-e Teng, Bo Jin, Ming-fang Zhao, Ping Yu, Jing Shi, Ling-Yu Fu, Zhen-ning Wang, Yun-peng Liu

Publikováno v: PLoS ONE, Vol 10, Iss 6, p e0128540 (2015)

Prognostic models are generally used to predict gastric cancer outcomes. However, no model combining patient-, tumor- and host-related factors has been established to predict outcomes after radical gastrectomy, especially outcomes of patients without

Externí odkaz: https://doaj.org/article/cbc2227c56b44d379cb9c2afffb487d7

Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural Network

Autor: Zai‐yi Liu, Zhu Liang, Yu Zongqiao, Chao Zhang, Shao-hong Huang, Yi-Long Wu, Xing Sun, Jie Qin, Feiyue Huang, Wen-Zhao Zhong, Yan‐bin Zhang, Wei-Neng Feng, Xue-Ning Yang, Xiaowei Guo, Qing Zhou, Chang Jia, Xing‐lin Gao, Tao Zhou, Yun‐sheng Wu, Xuegong Zhang, Ming‐fang Zhao, Ke Li, Kang Dang, Wei‐jun Fang

Publikováno v: The Oncologist. 24:1159-1165

Background Computed tomography (CT) is essential for pulmonary nodule detection in diagnosing lung cancer. As deep learning algorithms have recently been regarded as a promising technique in medical fields, we attempt to integrate a well-trained deep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272e0c8a4baaddcc8bcdba7a8603d496
https://doi.org/10.1634/theoncologist.2018-0908

A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel

Autor: Bao Hui Han, Yunpeng Liu, Jian Ping Xiong, Peng Hui Zhou, Yong Song, Xiaolong Fu, Wei Min Mao, Yuan Chen, Jizhen Lin, Gang Wu, Lin Wu, Jian Hua Chang, Wen-Zhao Zhong, Yun Fan, Jie Wang, Chun Chen, Jun Liang, Chang Li Wang, Wen Fan, Hao Sun, Shun Lu, Cheng Huang, Zhe Liu, Sheng Lin Ma, Jian Jun Wang, Gui Bin Qiao, Nong Yang, Qing Zhou, Yong He, Cai Cun Zhou, Cheng Ping Hu, He Long Zhang, Ji Feng Feng, Mei Lin Liao, Bo Zhu, Qun Wang, Qiong Zhao, X. Zhang, Qi Bin Song, Jie Hu, Zhong Zhen Guan, Chen Yan Gao, Yi-Long Wu, X.-N. Yang, Jin Ji Yang, Yue Yin Pan, Fan Yang, Ming Fang Zhao, Ying Cheng, Xiaoqing Liu, Jun Zhao, Yi Hu, Yan Fang Guan, Nan Wu, Ke-Neng Chen, Zhi Yong Ma

Publikováno v: Translational lung cancer research. 7(3)

The notable clinical success of cancer immunotherapy using checkpoint blockade suggests that it is likely to form the foundation of curative therapy for many malignancies. However, checkpoint blockades do not achieve sustained clinical response in mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89abbe1e8c35cc1f558ab9d1cc70881
https://pubmed.ncbi.nlm.nih.gov/30050780

The Role of E3 Ubiquitin Ligase Cbl Proteins in Interleukin-2-Induced Jurkat T-Cell Activation.

Autor: Ming-Fang Zhao¹, Xiu-Juan Qu¹, Jing-Lei Qu¹, You-Hong Jiang², Ye Zhang¹, Ke-Zuo Hou¹, Hao Deng¹, Yun-Peng Liu¹ cmuliuyunpeng@yahoo.cn

Publikováno v: BioMed Research International. 2013, Vol. 2013, p1-8. 8p.